https://www.selleckchem.com/pr....oducts/SB-431542.htm
Three patients (23%) presented mild nasopharyngeal, two patients (15%) bone marrow, and five patients (38%) splenic mild increase in glucose uptake. No patient had significant digestive focal or segmental glucose uptake. There was no significant physiological myocardial glucose uptake in all patients except one. There was no correlation between PET lung inflammatory status and chest CTevolution or short-term clinical outcome. Inflammatory process at the presumed peak of the inflammatory phase in COVID-19 patients is obvious in FDG PET